Plenary

Cell Signaling

Saturday, June 17
8:00 AM - 9:30 AM

Sponsored By: 

Jordan Pober

Presentation(s):

Send Email for Jordan Pober

Arthur Weiss

Ephraim P. Engleman Distinguished Professor Investigator, HHMI
University of California, San Francisco

Dr. Weiss is the Ephraim P. Engleman Distinguished Professor of Rheumatology in the Department of Medicine at the University of California San Francisco, where he has been on the faculty since 1985. He served as Division Chief of Rheumatology at UCSF from 1988-2011. He has been an Investigator of the Howard Hughes Medical Institute since 1985.
Dr. Weiss is a leading researcher in the field of signal transduction in the immune system, focusing on the roles of tyrosine kinases and phosphatases in regulating lymphocyte activation. He has studied how abnormalities in tyrosine phosphorylation pathways can lead to immunologically-mediated diseases.
Dr. Weiss is a member of the National Academy of Sciences, the National Academy of Medicine, and the American Academy of Arts and Sciences. He is a receipient of the Distinguished Investigator Award of the ACR, Arthritis Foundation’s Lee C. Howley Prize, and the American Association of Immunologists Meritorious Career Award.
Dr. Weiss a co-founder of Nurix, Inc. and is on the Scientific Advisory/Review Boards of Five Prime Therapeutics, Genentech, Molecular Stethoscope, and Portola Pharmaceuticals.

Presentation(s):

Send Email for Arthur Weiss

Jonathan Karn

Reinberger Professor and Chairman
Case Western Reserve University

Dr Karn is an internationally-recognized virologist who has made seminal contributions to the study of transcriptional control in HIV. Dr Karn’s current research focuses on epigenetic control mechanisms that regulate HIV transcription and latency in T-cells and microglial cells. Understanding these mechanisms is central to current efforts to induce or suppress latent viruses as part of an HIV eradication strategy.

As Chairman of the Department of Molecular Biology he oversaw a period of dramatic enhancement of the research portfolio, increasing the NIH funding base over 4-fold between 2002 and the present during a period of overall contraction for US research funding.

Dr Karn was elected a Fellow of the American Academy of Microbiology in 2011. He served as Chairman of the NIH AIDS Cell and Molecular Biology Study Section from (2005 to 2007) and is currently a member of the NIAID Advisory Council (2011 to 2015). He is currently a member of the Board of Scientific Counselors, Basic Sciences, of the National Cancer Institute (NCI) of the NIH.

He was the Executive Editor of the Journal of Molecular Biology from 1989 to 2011, and is currently on the editorial board of Journal of Biological Chemistry.

Presentation(s):

Send Email for Jonathan Karn

Facundo Batista

Associate Director
Ragon Institute of MGH, MIT and Harvard

Dr. Facundo Batista is the Associate Director of the Ragon Institute of MGH, MIT and Harvard and the Phillip and Susan Ragon Professor of Immunology at Harvard University and the Ragon Institute. Dr. Batista is a leader in the fields of B cell biology. During his scientific career, he has focused on addressing fundamental questions concerning the molecular and cellular events underlying B cell activation, fate determination and antibody responses. Dr. Batista received undergraduate degree from the University of Buenos Aires, Argentina, and his Ph.D. from the International School of Advances Studies, Trieste, Italy. He has trained as a postdoctoral fellow with Michael Neuberger at the Laboratory of Molecular Biology, Cambridge, UK. Prior to his appointment at the Ragon Institute, he was a Group Leader in the London Research Institute (now The Francis Crick Institute, UK) for the past 15 years.

Dr. Batista has served on the editorial boards of several journals such as Science, EMBO, Elife, Nature Cell Biology and Immunology. His attempts bridge basic B cell biology with health-related outcomes, led to the development of a novel strategy to generate monoclonal antibodies upon B cell stimulation, which lead to the spinoff company BliNK Therapeutics Ltd. Dr. Batista has been the recipient of several honors; he was elected to the EMBO Young Investigator Programme in 2009, and awarded EMBO full membership in 2013. He is also a recipient of the Royal Society Wolfson Research Merit Award and a Fellow of the Academy of Medical Science.

Presentation(s):

Send Email for Facundo Batista


Assets

Cell Signaling



Attendees who have favorited this

Send Email for Cell Signaling